Stockreport

Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement [Yahoo! Finance]

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF Protalix is granted an exclusive option to license any active compounds derived from the research for potential clinical development and commercialization CARMIEL, Is [Read more]